Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

Also called NCT03838328

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 360 participants (planned count) (from the registry)
Sponsor
SHI Jia (from the registry)
Registry
  • NCT NCT03838328
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03838328. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-01 (anticipated); primary completion 2020-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery
Condition
Thromboses, Deep Vein
Condition
Tranexamic Acid Adverse Reaction
Intervention (Drug)
Tranexamic Acid
Lead sponsor
SHI Jia (class: other)

Record details

Record id
cardio:ct-nct03838328
Content hash
78f94d36a4346f1c71d121a2d54910cc318ba6b2bfb643bd9747dd7640bd8b90